Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: This specification describes an associative memory cell capable of performing logic functions. The cell comprises two transistors with their collectors connected to an output line and their emitters connected to an input line carrying either the true or complement of one variable. The bases of the two transistors can each be selectively connected to either the true and complement of a second variable or fixed at one of two reference or logic levels to permit the performing of sixteen different logic functions of the two input variables by the cell.